Deep Piction introduced STV-C8, an AI-designed protein assembly engineered from the bottom up for RNA delivery.

Transforming Biotech: AI-Driven Cell-Level Imaging for Internal & Partner Drug Development Deep Piction is transforming biotechnological research and drug development with our unique tissue transparency platform and AI algorithms we developed. This proprietary technology generates the highest-resolution images, maps, and information of whole mammalian bodies, including intact human organs, at unparalleled cellular detail. This groundbreaking capability fuels our internal drug development pipeline by enabling unbiased, systems-level investigation of diseases at the cell level. For the very first time, we can develop precision medicine at the cellular level, significantly accelerating discovery and reducing reliance on animal testing. Imagine precisely tracking single CAR T cells to understand their efficacy, or visualizing exactly which cells gene delivery tools are targeting (and which they’re not) within an entire body. Our platform is not just for us; we have already worked with leading pharmaceutical companies that are keen to leverage our technology to gain unprecedented insights, accelerate pipelines, and tackle complex challenges in human health. Powered by advanced deep learning techniques and the world’s largest, highest-quality database of cell-level images, Deep Piction is building the future of precision therapeutics. Join us in unlocking the full potential of AI and cell-level imaging to improve human health and advance scientific discovery.

Founded 2022